Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension


Por: Bautista R., Manning R., Martinez F., Del Carmen Avila-Casado M., Soto V., Medina A., Escalante B.

Publicada: 1 ene 2004
Resumen:
Glucose uptake is increased in hypertension. Thus we investigated Na +-glucose cotransporter (SGLT2) activity and expression in proximal tubules from renovascular hypertensive rats. Sham-operated rats, aortic coarctation rats, and aortic coarctation rats treated with either ramipril (2.5 mg·kg-1·day-1 for 21 days) or losartan (10 mg·kg-1·day-1 for 21 days) were used. Na+-dependent glucose uptake was measured in brush-border membrane vesicles (BBMV). Vmax in BBMV from hypertensive rats was greater compared with those from normotensive rats (3 ± 0.2 vs. 1.5 ± 0.1 nmol·mg protein-1·min-1) without a change in Km. Renal immunostaining was greater, and Western blot analysis and RT-PCR showed. a higher expression of SGLT2 in hypertensive rats than in normotensive rats (1,029 ± 71 vs. 5,003 ± 292, 199 ± 15 vs. 95 ± 10, and 1.4 ± 0.2 vs. 0.3 ± 0.1 arbitrary units, respectively). In rats treated with either ramipril or losartan, V max decreased to 2.1 ± 0.3 and 1.8 ± 0.4 nmol·mg protein-1·min-1, respectively, as well as did the intensity of immunostaining and levels of protein and mRNA. We suggest that in renovascular hypertension, angiotensin II induced SGLT2 via the AT1 receptor, which was evidenced at both the functional and expression levels, probably contributing to increased absorption of Na + and thereby to the development or maintenance of hypertension.

Filiaciones:
Bautista R.:
 Department of Molecular Biomedicine, Ctro. de Invest. y Estud. Avanzados, Instituto Politecnico Nacional, Mexico City 07360, Mexico

Manning R.:
 Department of Molecular Biomedicine, Ctro. de Invest. y Estud. Avanzados, Instituto Politecnico Nacional, Mexico City 07360, Mexico

Martinez F.:
 Department of Pharmacology, Facultad de Medicina, Univ. Autonoma de S. Luis Potosi, San Luis Potosí 78000, Mexico

Del Carmen Avila-Casado M.:
 Department of Pathology, Inst. Nac. de Cardiologia I. Chavez, Mexico City 14080, Mexico

Soto V.:
 Department of Pathology, Inst. Nac. de Cardiologia I. Chavez, Mexico City 14080, Mexico

Medina A.:
 Department of Pathology, Inst. Nac. de Cardiologia I. Chavez, Mexico City 14080, Mexico

Escalante B.:
 Department of Molecular Biomedicine, Ctro. de Invest. y Estud. Avanzados, Instituto Politecnico Nacional, Mexico City 07360, Mexico

 Dept. of Molecular Biomedicine, Ctro. de Invest./Estud. Avanzados, IPN, Ave. Inst. Politecnico Nac. 2508, Mexico City 07360, Mexico
ISSN: 03636127
Editorial
American Physiological Society, Estados Unidos America
Tipo de documento: Article
Volumen: 286 Número: 1 55
Páginas: 127-133
WOS Id: 000186948600015
ID de PubMed: 14506074